T2DM
Conditions
Interventions
None listed
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1.Be older than 18 years old, male or female; 2.Dagagliptin is used during hospitalization (including initial use and previous long-term use); 3.Study group: For new patients, ketone body was negative before medication, but ketone body appeared after medication; In patients with previous long-term drug use, ketone bodies were tested positive during hospitalization. 4.Control group: patients who were newly taking daaglipzin or had taken daaglipzin for a long time before and after hospitalization and tested negative ketone body twice.
Exclusion criteria
Exclusion criteria: 1.For new patients, ketone body was positive before medication; 2.Incomplete medical records, including baseline data such as height and weight, drug use, disease information and test information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin leakage, dose reduction or withdrawal;recent operations;A disease or event that may affect the metabolic level of the body;duration of DM; | — |
Secondary
| Measure | Time frame |
|---|---|
| gender;recent drinking; | — |
Countries
China
Contacts
Public ContactZinan ZHAO
Beijing Hospital
Outcome results
None listed